Availability: 281 in stock Current findings are derived primarily from preclinical and experimental research settings
Qin P, Tang J, Sun D, Yang Y, Liu N, Li Y, et al
Mens Health Considerations No contraindications specific to male reproductive health exist, though long-term effects on spermatogenesis and endocrine parameters require further evaluation
Optimal Dosage and Injection Protocols for CJC1295 CJC1295 is typically dosed once daily or 23 times weekly , depending on the form: CJC1295 with DAC (Drug Affinity Complex): This long-acting version allows for 2 mg injected subcutaneously 12 times per week
Has Epitalon been tested in humans
[2] Products making explicit treatment or medicinal claims may be considered borderline medicinal products and could fall within MHRA regulatory scope